One of the best-selling, most famous medicines in history was never meant to do the thing it's famous for. The sildenafil inside Fildena began life as a heart drug — and only became a little blue revolution by accident, when a disappointing chest-pain trial threw up a result nobody had gone looking for.

A Drug Designed for the Heart

In the late 1980s, a team of Pfizer scientists at a laboratory in Sandwich, England, set out to treat angina — the chest pain caused by heart disease. Their compound, known at the time only by the code UK-92,480, was built to relax blood vessels by blocking an enzyme called PDE5, easing the strain on the heart. On paper, and in every intention behind it, this was a cardiovascular drug and nothing more.

The Trial That "Failed"

When the compound was tested in Wales in the early 1990s, its effect on angina turned out to be underwhelming — not nearly strong enough to justify a heart medicine. The project looked like a dead end. But the male volunteers kept reporting the same curious, unbidden side effect: erections. The drug that was flopping at its intended job had quietly stumbled onto something else entirely. The most-repeated detail of the whole saga is that some participants were oddly reluctant to hand back their leftover tablets.

From Reject to Revolution

Pfizer changed direction, studied the compound properly for erectile dysfunction, and in 1998 it became the first oral ED pill ever approved — a blockbuster almost overnight. There's a neat coincidence buried in the timing, too: that very same year, the Nobel Prize in Medicine was awarded for the discovery of nitric oxide as a signaling molecule — the exact bit of body chemistry that explains how the drug works in the first place.

The Full Circle

Here's the twist on the twist. Sildenafil eventually found its way back to its cardiovascular roots after all. Under a different name, it's now an approved treatment for high blood pressure in the lungs, and it's been studied for everything from altitude sickness to managing pressure in the lungs after heart surgery. The "failed heart drug" turned out to be a heart-and-lung drug all along — it simply took a world-famous detour to get there. For more on the unlikely story behind sildenafil, the detailed guide is a fascinating read.

One for the Garden

And a final oddity for good measure. Because the blood-flow chemistry it tinkers with isn't unique to human beings, researchers once discovered that a small amount of sildenafil added to the water in a vase kept cut flowers standing upright and fresh for noticeably longer. The little blue pill, it turns out, has a surprisingly green thumb.

The whole story is a reminder that some of medicine's biggest breakthroughs don't arrive by careful design at all — they walk in sideways, disguised as a failure, and only later reveal what they were really for.